P-0132” for the treatment of Dry Eye Disease The Clinical Trials use a novel compound discovered by Mochida and licensed to Senju Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President:...
https://www.senju.co.jp/sites/default/files/content_news/2023-03/ENG_20230322.pdf